Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of the Clinical,Serological and Genetic Factors That Determine Primary Non-response, Loss of Response and Adverse Drug Reactions to Anti-TNF Drugs in Patients With Active Luminal Crohn's Disease

NCT03088449 is registered in ClinicalTrials.gov with Royal Devon and Exeter NHS Foundation Trust as lead sponsor.

NCT NCT03088449
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03088449 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of the Clinical,Serological and Genetic Factors That Determine Primary Non-response, Loss of Response and Adverse Drug Reactions to Anti-TNF Drugs in Patients With Active Luminal Crohn's Disease
Lead sponsor
Royal Devon and Exeter NHS Foundation Trust
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2013
Completion date
July 30, 2019
Enrollment
1,750 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease